AJOONIAnimal Feed
Ajooni Biotech Ltd — Cash Flow Statement
₹3.84
-3.98%
Ajooni Biotech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -19.77 Cr | 17.31 Cr | -8.44 Cr | 1.56 Cr | — |
| Issuance Of Capital Stock | 25.39 Cr | 0.00 | 22.31 Cr | 0.00 | — |
| Capital Expenditure | -2.03 Cr | -5.60 Cr | -2.86 Cr | -2.12 Cr | — |
| End Cash Position | -9.62 Cr | 27.29 Cr | 0.31 Cr | 0.06 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -36000.00 | -3000.00 | -1000.00 | 1000.00 | — |
| Beginning Cash Position | 0.43 Cr | 0.31 Cr | 0.06 Cr | 0.24 Cr | — |
| Changes In Cash | -10.04 Cr | 26.98 Cr | 0.25 Cr | -0.19 Cr | — |
| Financing Cash Flow | 24.83 Cr | -3.57 Cr | 21.66 Cr | -1.97 Cr | — |
| Interest Paid Cff | -0.33 Cr | -0.56 Cr | -0.48 Cr | -0.54 Cr | — |
| Net Common Stock Issuance | 25.39 Cr | 0.00 | 22.31 Cr | 0.00 | — |
| Common Stock Issuance | 25.39 Cr | 0.00 | 22.31 Cr | 0.00 | — |
| Net Issuance Payments Of Debt | -0.23 Cr | -3.01 Cr | -0.17 Cr | -1.43 Cr | — |
| Net Short Term Debt Issuance | -0.49 Cr | -2.94 Cr | 0.66 Cr | -2.11 Cr | — |
| Net Long Term Debt Issuance | 0.26 Cr | -0.06 Cr | -0.83 Cr | 0.68 Cr | — |
| Investing Cash Flow | -17.13 Cr | 7.64 Cr | -15.82 Cr | -1.90 Cr | — |
| Interest Received Cfi | 0.89 Cr | 0.50 Cr | 0.20 Cr | 6000.00 | — |
| Net Investment Purchase And Sale | -16.95 Cr | 12.70 Cr | -13.17 Cr | 0.13 Cr | — |
| Purchase Of Investment | -16.95 Cr | — | -13.17 Cr | 0.00 | — |
| Net PPE Purchase And Sale | -1.08 Cr | -5.57 Cr | -2.86 Cr | 0.10 Cr | — |
| Sale Of PPE | 0.96 Cr | 0.03 Cr | 40000.00 | 0.10 Cr | — |
| Purchase Of PPE | -2.03 Cr | -5.60 Cr | -2.86 Cr | 0.00 | — |
| Operating Cash Flow | -17.74 Cr | 22.91 Cr | -5.58 Cr | 3.68 Cr | — |
| Taxes Refund Paid | -0.88 Cr | -0.54 Cr | -0.45 Cr | -0.16 Cr | — |
| Change In Working Capital | -21.73 Cr | 19.53 Cr | -8.09 Cr | 0.72 Cr | — |
| Change In Other Current Liabilities | 0.26 Cr | 1.09 Cr | 1.09 Cr | 32000.00 | — |
| Change In Other Current Assets | -2.23 Cr | 2.54 Cr | -2.78 Cr | 0.11 Cr | — |
| Change In Payable | 1.91 Cr | 8.53 Cr | 3.31 Cr | 1.40 Cr | — |
| Change In Inventory | -8.62 Cr | -0.74 Cr | -1.11 Cr | -0.51 Cr | — |
| Change In Receivables | -13.05 Cr | 8.11 Cr | -8.60 Cr | -0.29 Cr | — |
| Other Non Cash Items | -0.55 Cr | 0.06 Cr | 0.27 Cr | 0.68 Cr | — |
| Depreciation And Amortization | 1.09 Cr | 0.87 Cr | 1.00 Cr | 0.97 Cr | — |
| Depreciation | 1.09 Cr | 0.87 Cr | 1.00 Cr | 0.97 Cr | — |
| Gain Loss On Investment Securities | -18000.00 | — | 1000.00 | 0.01 Cr | — |
| Net Income From Continuing Operations | 4.33 Cr | 3.00 Cr | 1.58 Cr | 1.46 Cr | — |
| Dividends Received Cfi | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Of Investment | — | 12.70 Cr | — | 0.13 Cr | — |
| Provisionand Write Offof Assets | — | 0.00 | 0.11 Cr | 0.00 | — |
| Net Other Financing Charges | — | — | 14.79 Cr | -1000.00 | 0.60 Cr |
| Net Other Investing Changes | — | — | 1000.00 | -1000.00 | 0.12 Cr |
| Net Intangibles Purchase And Sale | — | — | -1.36 Cr | -2.12 Cr | — |
| Purchase Of Intangibles | — | — | -1.36 Cr | -2.12 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ajooni Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.